Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098708 · ClinicalTrials.gov registry record
This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy
A clinical trial of Duchenne Muscular Dystrophy, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01098708 is a study of Duchenne Muscular Dystrophy that has completed, run by Washington University School of Medicine. The registered enrollment target is 50 participants, below the 411-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01098708, a study of Duchenne Muscular Dystrophy, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Many therapeutic trials in DMD exclude non-ambulatory boys and men. Rate of progression in these non-ambulatory patients has been studied but consensus has not been reached for what measures are most reliable and reproducible. Furthermore, any treatment trial would be expected to demonstrate improved function and improvement in quality of life. Therefore, function, strength, and quality of life must be understood and standardized. While the goal of this proposal is to standardize clinical outcomes for therapeutic trials, careful understanding of the progression of DMD in non ambulatory boys may also lead to better medical treatment.
Conditions Studied
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098708
The ClinicalTrials.gov registry entry for NCT01098708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 411-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (88% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT01098708 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01098708 about?
NCT01098708 is a clinical study titled "This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy". Many therapeutic trials in DMD exclude non-ambulatory boys and men. Rate of progression in these non-ambulatory patients has been studied but consensus has not been reached for what measures are most reliable and reproducible. Furthermore, any treatment trial would be expected to demonstrate improve...
What is the current status of trial NCT01098708?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-03. Estimated completion is 2013-11.
What conditions does trial NCT01098708 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy.
Who is sponsoring clinical trial NCT01098708?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01098708 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
The Duchenne Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.